ALPHARETTA, Ga., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery of therapies to ...
ALPHARETTA, Ga., July 31, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical (CLSD), Inc. , a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the ...
CLEAR LAKE, TX / ACCESSWIRE / June 18, 2024 / CLS Health, a leader in comprehensive healthcare, proudly announces the grand opening of its new expansive multi-specialty building, marking a significant ...
ALPHARETTA, Ga., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve ...
HOUSTON, TEXAS / ACCESS Newswire / April 14, 2025 / CLS Health has expanded its specialty care offerings with the launch of full-spectrum ophthalmology and optometry services at its Clear Lake Campus.
- BCVA and CST Data from Sub-Group Analyses Provide Key Insights for Planned CLS-AX Phase 3 Trial Design - ALPHARETTA, Ga., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results